NCT06462482View on ClinicalTrials.gov

Peri-Operative Testosterone Administration in Primary Hip Arthroscopy

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Femoro Acetabular Impingement
Interventions
DRUG

Nandrolone Decanoate

Nandrolone will be administered to the testosterone group, specifically a 200mg dose weekly for 8 weeks beginning 2 weeks prior to surgery.

DRUG

Saline

Saline will be administered to the saline group, specifically a 200mg dose weekly for 8 weeks beginning 2 weeks prior to surgery.

Sponsors
All Listed Sponsors
lead

American Hip Institute

OTHER